Affiliation:
1. Division of Pediatric Endocrinology, Icahn School of Medicine at Mount Sinai , New York, NY 10029 , USA
Abstract
Abstract
β-Thalassemia is characterized by the abnormal synthesis of β-hemoglobin chains resulting in hemolytic anemia. Treatment involves frequent blood transfusions, which leads to deposition of iron in many organs, including endocrine glands. To date, several cases of papillary thyroid cancer (PTC) in patients with β-thalassemia have been reported in the adult literature, but there have been none in pediatrics. Here we report on an female adolescent with β-thalassemia who initially presented for evaluation of secondary amenorrhea. On examination, her thyroid gland was asymmetric, firm in consistency, with palpable lymph nodes along the right anterior cervical chain. A thyroid ultrasound revealed an enlarged right lobe containing 3 focal hypoechoic masses with calcific foci. Biopsy was consistent with PTC. She underwent total thyroidectomy and histological examination confirmed the diagnosis. Her postoperative course was uncomplicated and she was started on replacement therapy with levothyroxine. This is the first reported case of PTC in a pediatric patient with β-thalassemia. The incidence of thyroid cancer in patients with β-thalassemia is currently unknown; however, there may be utility in routine surveillance of this patient population.
Reference9 articles.
1. Malignancies and thalassemia: a review of the literature;Zanella;Ann N Y Acad Sci,2016
2. New trends in the treatment of beta-thalassemia;Rund;Crit Rev Oncol Hematol,2000
3. Endocrine complications in patients with thalassaemia Major;Toumba;Pediatr Endocrinol Rev,2007
4. An ICET-A survey on occult and emerging endocrine complications in patients with beta-thalassemia major: conclusions and recommendations;De Sanctis;Acta Biomed,2019
5. Malignancies in beta-thalassemia patients: first description of two cases of thyroid cancer and review of the literature;Poggi;Hemoglobin,2011